Oncological Outcomes of Patients with Non-Clear Cell Renal Cell Cancers: Subtypes of Unclassified and Translocation Renal Cell Cancers
dc.authorid | Celik, Serdar/0000-0003-0939-9989 | |
dc.authorid | Aslan, Guven/0000-0003-3715-1761 | |
dc.contributor.author | Gokalp, Fatih | |
dc.contributor.author | Celik, Serdar | |
dc.contributor.author | Sozen, Tevfik Sinan | |
dc.contributor.author | Ozen, Abdurrahim Haluk | |
dc.contributor.author | Aslan, Guven | |
dc.contributor.author | Izol, Volkan | |
dc.contributor.author | Baltaci, Sumer | |
dc.date.accessioned | 2024-09-18T20:28:17Z | |
dc.date.available | 2024-09-18T20:28:17Z | |
dc.date.issued | 2023 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | Purpose: We aimed to compare oncological outcomes in the two rare subtypes, unclassified renal cell cancer (un-RCC) and translocation RCC (tRCC), vs clear cell RCC (ccRCC). Materials and Methods: Between 2004 and 2019, from Turkish Urooncology Society Database, we identified 2324 patients for histological subtypes including 80 unRCC (3.4%), 19 tRCC (0.8%) and 2225 ccRCC (95.8%). Results: The overall (15.8%) and cancer-specific mortalities (11.1%) were found to be higher in tRCC group and the recurrence free mortality (13.8%) was found to be higher in unRCC group. Larger pathological tumor size (p = 0.012) and advanced pathological T stage (p = 0.042) were independent predictive factors on overall mortality in patients with unRCC tumors. Conclusion: The oncological outcomes of the unRCC and tRCC are worse than ccRCC and pathological tumor size and pathological stage are predictive factors for mortality in the unRCC. | en_US |
dc.identifier.doi | 10.22037/uj.v19i.7091 | |
dc.identifier.endpage | 33 | en_US |
dc.identifier.issn | 1735-1308 | |
dc.identifier.issn | 1735-546X | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 35892147 | en_US |
dc.identifier.scopus | 2-s2.0-85145425430 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 29 | en_US |
dc.identifier.uri | https://doi.org/10.22037/uj.v19i.7091 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/10828 | |
dc.identifier.volume | 20 | en_US |
dc.identifier.wos | WOS:000905440500005 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Urol & Nephrol Res Ctr-Unrc | en_US |
dc.relation.ispartof | Urology Journal | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | kidney | en_US |
dc.subject | kidney cancer | en_US |
dc.subject | oncology | en_US |
dc.subject | pathology | en_US |
dc.title | Oncological Outcomes of Patients with Non-Clear Cell Renal Cell Cancers: Subtypes of Unclassified and Translocation Renal Cell Cancers | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1